Drugs / GRC 17356
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01726413 | Nov 2012 → Aug 2014 | diabetic polyneuropathy | Glenmark Pharmaceuticals Ltd. India | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GRC 17356 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01726413 ↗ |